Elinor Wilson
Encyclopedia
Dr. Elinor Wilson is the current President of Assisted Human Reproduction Canada
, appointed February 14, 2007 until February 13, 2012
Dr. Wilson has a Master of Health Sciences from McMaster University, and PhD in Administration Management from Walden University in Minneapolis, Minnesota.
Prior to her appointment with AHRC Dr. Wilson served as Chief Executive Officer for the Canadian Public Health Association, responsible for managing an operating program and project budget in excess of $15 million, and for building relationships with stakeholders, members, partners and donors across the public, private and NGO sectors. Dr. Wilson has also held a number of increasingly responsible positions with the Heart and Stroke Foundation of Canada.
Her professional activates are numerous, including past-member of the Institute of Population and Public Health Advisory Board at the Canadian Institutes of Health Research, and the Canadian Population Health Initiative Board. She was formerly Vice President of the World Heart Federation, President on the InterAmerican Heart Federation, and member of the WHO Expert Advisory Group on Global Cessation Policy. During the WHO deliberations on the Framework Convention on Tobacco Control (FCTC) she was the NGO representative on the Canadian Government delegation to the FCTC.
Assisted Human Reproduction Canada
Assisted Human Reproduction Canada is a federal regulatory agency that was established in 2006 to protect and promote the health, safety, dignity and rights of Canadians who use or are born of assisted human reproduction technologies...
, appointed February 14, 2007 until February 13, 2012
Education
Dr. Elinor Wilson, PhD, MHSc, RN.Dr. Wilson has a Master of Health Sciences from McMaster University, and PhD in Administration Management from Walden University in Minneapolis, Minnesota.
Career
In December, 2006 Dr. Wilson was appointed President of Assisted Human Reproduction Canada (AHRC). The Agency is a regulatory agency of the Government of Canada, established by an Act of Parliament. As President, she is responsible to provide strategic leadership; manage the day-to-day activities of the Agency; develop corporate strategies and performance measurements; promote excellence and networking; and provide sound and informed advice in a sensitive domain.Prior to her appointment with AHRC Dr. Wilson served as Chief Executive Officer for the Canadian Public Health Association, responsible for managing an operating program and project budget in excess of $15 million, and for building relationships with stakeholders, members, partners and donors across the public, private and NGO sectors. Dr. Wilson has also held a number of increasingly responsible positions with the Heart and Stroke Foundation of Canada.
Her professional activates are numerous, including past-member of the Institute of Population and Public Health Advisory Board at the Canadian Institutes of Health Research, and the Canadian Population Health Initiative Board. She was formerly Vice President of the World Heart Federation, President on the InterAmerican Heart Federation, and member of the WHO Expert Advisory Group on Global Cessation Policy. During the WHO deliberations on the Framework Convention on Tobacco Control (FCTC) she was the NGO representative on the Canadian Government delegation to the FCTC.